CanSino Biologics, Inc. Class H (6185) Income Statement

Last quarter (Q4 2024), CanSino Biologics, Inc. Class H's total revenue was ¥279.26M, an increase of 64.71% from the same quarter last year. In Q4, CanSino Biologics, Inc. Class H's net income was ¥-156.47M. See CanSino Biologics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.